Q4A8Y0 AF NFT

Isoleucine--tRNA ligase

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeig26st4blesoefqndbsi67gg4yv2h4z6x626vbxmlr5xnlhl43mr4/metadata.json
IPFS of structure file: 
bafybeidpoc5tpqoe74zlrm4jybhfqndd5v22np6qpcedbue7zknoueh4ba/AF-Q4A8Y0-F1-model_v2.pdb
First NFT owner address (eip-55): 
0xEa58c7534E5701aA8370E0fAEb19b7e14653e69c
First NFT owner address (bech32): 
genesis1afvvw56w2uq64qmsurawkxdhu9r98e5uajuhsx
Current NFT ID #449012 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1

NFT id:
449012
Accession (UniProt):
Q4A8Y0
Name::
Isoleucine--tRNA ligase
Experimental Method:
Predicted structure
Sequence source:
Mycoplasma hyopneumoniae (strain 7448)

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT Q4A8Y0 research and analysis (ICN3D with VR)

FASTA sequences

>sp|Q4A8Y0|SYI_MYCH7 Isoleucine--tRNA ligase OS=Mycoplasma hyopneumoniae (strain 7448) OX=262722 GN=ileS PE=3 SV=2 MDKNFYKNSLNIFNSNFSMKANLSEKDKFYADFWEKNQIYQQILRKRRGNPRFILHDGPPYANGDIHIGHALNKILKDIIVRYKTMAGFYSPFVPGWDTHGLPIENKIINQIGSKSTLEIRRKSNDFANSQILAQMAQFKKLNLLTDFKQIYQTNTPNYEAKQLKLFKKMVSRGLVYRALKPVYWSPSSQSALAEAEIEYLEYRSPSLFTSFDIKKGNNFVAENDKLIIWTTTPWTLIANSGVAVGENFDYVRIKNEENFYVLAANLLEKLAAIFDWKHYEIIDNFPGKSILGIKYLHPIFEKICPIVSGNHVSLDVGSGLVHLAPLFGEDDYWIGRENNLEMVMHVNDDGKFNENAGQFSGQFYANSNKLITEFLEKKSKILHLSFIDHSFPHDWRTLKPVIYRGTPQWFVSIEKIKKDLEKAIEEIEFPENWLKKRLTKMVVERKDWLISRQRSWGIPLIIFYDQNKEPVLDKPEIFDYIISLVEKFGSRIWYEKTTDELLPEKYQNLGWTKENDILDVWFDSGVSFFAANISDEKPPFDIYFEGSDQYRGWFNSSLINSVIYFGFSPYKKLLSHGFVVDAKGNKMSKSRGNGVDPLVILSKYGCDIFRLWVANSEYYNDIVYSEAIFEQNVEIYRKIRNTVRFLITNLADFKPKKYELTEVDLYIFNKIQKLKNEIIQNYDQNRFVRVVKIINNFIIEFSNFYLSIVKDILYADKKESLKRRQVQYNLYELLQVLNIAIAPIMPTTAEEIYSFIQKNNKQISVHMEEFFKESHFDEELVAKWDEFFQIKDSVYQLIEQKIKSKEIKRPNEVGVLLKTDSDFIKSIDLEKLLMVAKVEFSNEKTEILQLNWEKCPRCWNHFEKINKVCARCFEVLSEIVPEKNS